About Questcor
We are a biopharmaceutical company focused on providing prescription drugs for the treatment of rare central nervous system and inflammatory disorders. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.
Our main product is H.P Acthar® Gel (repository corticotropin hormone), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component.
We are currently supporting research in a number of rare conditions, including treatment-resistant patient populations, where there is significant need for better therapeutic options. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.
Prescriptions and Reimbursement Support
Questcor is dedicated to supporting patients at each step of the treatment process. With this in mind, Questcor personnel created the Acthar Support and Access Program (ASAP).
The Acthar Support & Access Program (ASAP) does the following:
- Contacts the patient's insurance company
- Investigates benefits and facilitates any prior authorizations if necessary
- Routes the prescription to the appropriate specialty pharmacy for fulfillment
- Ships Acthar and the necessary supplies next day for overnight delivery to the patient's home or alternate location under the appropriate temperature-controlled conditions
Acther®
Acthar (repository corticotropin injection) is natural source ACTH (adrenocorticotropic hormone) in 16% gelatin to provide a prolonged release after intramuscular or subcutaneous injection.
Acthar may be used in the treatment of acute exacerbations of multiple sclerosis as well as a range of other diseases and disorders having a central nervous system or inflammatory component. For a full list of approved indications, please see the Acthar prescribing information. In the treatment of acute exacerbations of multiple sclerosis daily intramuscular doses of 80-120 units for 2-3 weeks may be administered. Your healthcare provider will determine the specific dosage that is best for you.